Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2025-12-24 @ 3:17 PM
NCT ID:
NCT03988192
Eligibility Criteria:
Inclusion Criteria:
* patient aged \> 18 years old
* patient with metastatic non-small cell lung cancer with marketing authorisation criteria for immunotherapy
* preserved overall condition (Performans Status 1)
* signed informed consent
* patient with healthcare insurance
Non Inclusion Criteria:
* patient with oxygen therapy or invasive ventilation
* patient unable to perform a slow vital capacity
* systemic corticosteroid therapy more than 10 mg per day of prednisone equivalent
* previous treatment with immunotherapy
* dermatological therapy interfering with sweat collection (psoriasis, irritant dermatitis, for instance)
* Patient deprived of liberty by judicial or administrative decision
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03988192
Study Brief:
Protocol Section:
NCT03988192